US Broker Ratings

Apogee Therapeutics, Inc. (APGE): An Insightful Stock Analysis on Growth Potential and Market Position

Apogee Therapeutics, Inc. (APGE), a clinical-stage biotechnology company, is capturing the attention of investors with its innovative approach to treating inflammatory and immunology indications. Headquartered in..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating Uncharted Valuation Waters with Promising Revenue Growth

Twist Bioscience Corporation (NASDAQ: TWST) stands at the intersection of synthetic biology and healthcare innovation, offering products pivotal to advancements in therapeutics, diagnostics, and beyond. With..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 74.72% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) is capturing the attention of investors with its impressive potential upside of 74.72%, based on current analyst ratings. As a significant..

Vericel Corporation (VCEL) Stock Analysis: Navigating a 37.82% Potential Upside Amidst Strong Revenue Growth

Vericel Corporation (NASDAQ: VCEL), a prominent player in the healthcare sector, is making waves in the biotechnology industry with its specialized cellular therapies and biologic products...

Concentra Group Holdings Parent (CON) Stock Analysis: A Strong Healthcare Play with Robust Analyst Confidence

Concentra Group Holdings Parent, Inc. (NASDAQ: CON) is an intriguing player in the healthcare sector, specifically within the medical care facilities industry. With a market cap..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 38% Upside Potential in Biotech

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is gaining the attention of investors with its strategic focus on developing therapies for..

NovoCure Limited (NVCR) Investor Outlook: Exploring a Potential 56.80% Upside in the Healthcare Sector

NovoCure Limited (NASDAQ: NVCR), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with a potential upside of 56.80%. Headquartered..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Powerhouse with 42% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a leading biopharmaceutical company based in China, has captured the attention of the investment community with its robust pipeline and strategic..

ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring a 70% Upside Potential

ImmunityBio, Inc. (NASDAQ: IBRX) is carving a niche in the biotechnology sector with its robust focus on next-generation immunotherapies. Leveraging cutting-edge platforms, the San Diego-based company..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: 61% Upside Potential Amid Biotech Innovations

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company headquartered in Zug, Switzerland, is attracting attention in the healthcare sector with its promising innovations targeting inflammatory skin..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Potential 169% Upside Amid Strong Buy Ratings

Investors looking for promising opportunities in the biotechnology sector may want to keep a close eye on Viking Therapeutics, Inc. (NASDAQ: VKTX). The San Diego-based company,..

Xenon Pharmaceuticals Inc. (XENE): Analyst Consensus Highlights 26.65% Potential Upside

Xenon Pharmaceuticals Inc. (XENE), a trailblazer in the biotechnology landscape focused on neurological and psychiatric disorders, is drawing significant attention in the healthcare sector. With a..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring an 83.24% Potential Upside in Biotech

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector, is capturing the attention of investors with its potential upside of 83.24%. Headquartered..

LifeStance Health Group (LFST) Investor Outlook: Analyzing Growth Potential Amid Strong Revenue Growth and Analyst Confidence

LifeStance Health Group, Inc. (NASDAQ: LFST), a healthcare company specializing in outpatient mental health services, has captured investor attention with its robust revenue growth and positive..

Warby Parker Inc. (WRBY) Stock Analysis: Exploring the 15% Upside Potential and Analyst Confidence

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, specializing in medical instruments and supplies, has carved a niche for itself in the..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring an 18% Potential Upside with Strong Revenue Growth

Harmony Biosciences Holdings, Inc. (HRMY) stands as a compelling player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $2.27 billion,..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: A Biotech Gem with 24.74% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is capturing significant investor attention with its promising pipeline and robust market potential. With..

Alvotech (ALVO) Stock Analysis: Potential Upside and Strategic Positioning in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based biosimilar manufacturer, is carving out a notable niche in the healthcare sector, particularly within the specialty and generic drug manufacturing industry...

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring the Biotech’s Unprecedented 3,749% Revenue Growth

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has carved a niche in the biotechnology sector with its innovative approach to treating complex medical conditions. With a staggering 3,749.20%..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: High ROE and Revenue Growth Highlight Investment Potential

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a key player in the global biopharmaceutical landscape, is attracting investor attention with its robust 613.02% return on equity (ROE) and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds